Industry: Chemical & Material
Published Date: 2025-07-07
Pages: 79 Pages
Report ld: 4786239
Request Sample
Customized Report
Testosterone Undecanoate API Market Size(US$)

CAGR 2025-2031
4.8%
Market Size,2031
USD 212
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Testosterone Undecanoate API market size was US$ 153 million in 2024 and is forecast to a readjusted size of US$ 212 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Testosterone Undecanoate API market competitiveness, regional economic performance, and supply chain configurations.
Testosterone Undecanoate API is widely used in the pharmaceutical industry to manufacture testosterone injections, oral preparations, etc. Testosterone undecanoate is a synthetic testosterone drug commonly used to treat male diseases such as testosterone deficiency or testicular dysfunction. It is a long-acting esterified form of testosterone that binds with undecyl acid to slowly release it in the body, prolonging its efficacy.
The North America Testosterone Undecanoate API market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Testosterone Undecanoate API include Pfizer, Symbiotec, Steroid S.p.A., Aspen, Amber Lifesciences, Trifarma, ASG Biochem, Huvepharma, Xianju Pharmaceutical, Zhejiang Shenzhou Pharmaceutical, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Testosterone Undecanoate API market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Testosterone Undecanoate API market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Purity<99% in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Biological Research in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Testosterone Undecanoate API value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Testosterone Undecanoate API Product Scope
1.2 Testosterone Undecanoate API by Type
1.2.1 Global Testosterone Undecanoate API Sales by Type (2020 & 2024 & 2031)
1.2.2 Purity≥99%
1.2.3 Purity<99%
1.3 Testosterone Undecanoate API by Application
1.3.1 Global Testosterone Undecanoate API Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Pharmaceutical
1.3.3 Biological Research
1.4 Global Testosterone Undecanoate API Market Estimates and Forecasts (2020-2031)
1.4.1 Global Testosterone Undecanoate API Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Testosterone Undecanoate API Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Testosterone Undecanoate API Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Testosterone Undecanoate API Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Testosterone Undecanoate API Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Testosterone Undecanoate API Sales Market Share by Region (2020-2025)
2.2.2 Global Testosterone Undecanoate API Revenue Market Share by Region (2020-2025)
2.3 Global Testosterone Undecanoate API Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Testosterone Undecanoate API Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Testosterone Undecanoate API Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Testosterone Undecanoate API Market Size and Prospective (2020-2031)
2.4.2 Europe Testosterone Undecanoate API Market Size and Prospective (2020-2031)
2.4.3 China Testosterone Undecanoate API Market Size and Prospective (2020-2031)
2.4.4 Japan Testosterone Undecanoate API Market Size and Prospective (2020-2031)
2.4.5 India Testosterone Undecanoate API Market Size and Prospective (2020-2031)
2.4.6 Southeast Asia Testosterone Undecanoate API Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Testosterone Undecanoate API Historic Market Review by Type (2020-2025)
3.1.1 Global Testosterone Undecanoate API Sales by Type (2020-2025)
3.1.2 Global Testosterone Undecanoate API Revenue by Type (2020-2025)
3.1.3 Global Testosterone Undecanoate API Price by Type (2020-2025)
3.2 Global Testosterone Undecanoate API Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Testosterone Undecanoate API Sales Forecast by Type (2026-2031)
3.2.2 Global Testosterone Undecanoate API Revenue Forecast by Type (2026-2031)
3.2.3 Global Testosterone Undecanoate API Price Forecast by Type (2026-2031)
3.3 Different Types Testosterone Undecanoate API Representative Players
4 Global Market Size by Application
4.1 Global Testosterone Undecanoate API Historic Market Review by Application (2020-2025)
4.1.1 Global Testosterone Undecanoate API Sales by Application (2020-2025)
4.1.2 Global Testosterone Undecanoate API Revenue by Application (2020-2025)
4.1.3 Global Testosterone Undecanoate API Price by Application (2020-2025)
4.2 Global Testosterone Undecanoate API Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Testosterone Undecanoate API Sales Forecast by Application (2026-2031)
4.2.2 Global Testosterone Undecanoate API Revenue Forecast by Application (2026-2031)
4.2.3 Global Testosterone Undecanoate API Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Testosterone Undecanoate API Application
5 Competition Landscape by Players
5.1 Global Testosterone Undecanoate API Sales by Players (2020-2025)
5.2 Global Top Testosterone Undecanoate API Players by Revenue (2020-2025)
5.3 Global Testosterone Undecanoate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Undecanoate API as of 2024)
5.4 Global Testosterone Undecanoate API Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Testosterone Undecanoate API, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Testosterone Undecanoate API, Product Type & Application
5.7 Global Key Manufacturers of Testosterone Undecanoate API, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Testosterone Undecanoate API Sales by Company
6.1.1.1 North America Testosterone Undecanoate API Sales by Company (2020-2025)
6.1.1.2 North America Testosterone Undecanoate API Revenue by Company (2020-2025)
6.1.2 North America Testosterone Undecanoate API Sales Breakdown by Type (2020-2025)
6.1.3 North America Testosterone Undecanoate API Sales Breakdown by Application (2020-2025)
6.1.4 North America Testosterone Undecanoate API Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Testosterone Undecanoate API Sales by Company
6.2.1.1 Europe Testosterone Undecanoate API Sales by Company (2020-2025)
6.2.1.2 Europe Testosterone Undecanoate API Revenue by Company (2020-2025)
6.2.2 Europe Testosterone Undecanoate API Sales Breakdown by Type (2020-2025)
6.2.3 Europe Testosterone Undecanoate API Sales Breakdown by Application (2020-2025)
6.2.4 Europe Testosterone Undecanoate API Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Testosterone Undecanoate API Sales by Company
6.3.1.1 China Testosterone Undecanoate API Sales by Company (2020-2025)
6.3.1.2 China Testosterone Undecanoate API Revenue by Company (2020-2025)
6.3.2 China Testosterone Undecanoate API Sales Breakdown by Type (2020-2025)
6.3.3 China Testosterone Undecanoate API Sales Breakdown by Application (2020-2025)
6.3.4 China Testosterone Undecanoate API Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Testosterone Undecanoate API Sales by Company
6.4.1.1 Japan Testosterone Undecanoate API Sales by Company (2020-2025)
6.4.1.2 Japan Testosterone Undecanoate API Revenue by Company (2020-2025)
6.4.2 Japan Testosterone Undecanoate API Sales Breakdown by Type (2020-2025)
6.4.3 Japan Testosterone Undecanoate API Sales Breakdown by Application (2020-2025)
6.4.4 Japan Testosterone Undecanoate API Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Testosterone Undecanoate API Sales by Company
6.5.1.1 India Testosterone Undecanoate API Sales by Company (2020-2025)
6.5.1.2 India Testosterone Undecanoate API Revenue by Company (2020-2025)
6.5.2 India Testosterone Undecanoate API Sales Breakdown by Type (2020-2025)
6.5.3 India Testosterone Undecanoate API Sales Breakdown by Application (2020-2025)
6.5.4 India Testosterone Undecanoate API Major Customer
6.5.5 India Market Trend and Opportunities
6.6 Southeast Asia Market: Players, Segments, Downstream and Major Customers
6.6.1 Southeast Asia Testosterone Undecanoate API Sales by Company
6.6.1.1 Southeast Asia Testosterone Undecanoate API Sales by Company (2020-2025)
6.6.1.2 Southeast Asia Testosterone Undecanoate API Revenue by Company (2020-2025)
6.6.2 Southeast Asia Testosterone Undecanoate API Sales Breakdown by Type (2020-2025)
6.6.3 Southeast Asia Testosterone Undecanoate API Sales Breakdown by Application (2020-2025)
6.6.4 Southeast Asia Testosterone Undecanoate API Major Customer
6.6.5 Southeast Asia Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Testosterone Undecanoate API Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Pfizer Testosterone Undecanoate API Products Offered
7.1.5 Pfizer Recent Development
7.2 Symbiotec
7.2.1 Symbiotec Company Information
7.2.2 Symbiotec Business Overview
7.2.3 Symbiotec Testosterone Undecanoate API Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Symbiotec Testosterone Undecanoate API Products Offered
7.2.5 Symbiotec Recent Development
7.3 Steroid S.p.A.
7.3.1 Steroid S.p.A. Company Information
7.3.2 Steroid S.p.A. Business Overview
7.3.3 Steroid S.p.A. Testosterone Undecanoate API Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Steroid S.p.A. Testosterone Undecanoate API Products Offered
7.3.5 Steroid S.p.A. Recent Development
7.4 Aspen
7.4.1 Aspen Company Information
7.4.2 Aspen Business Overview
7.4.3 Aspen Testosterone Undecanoate API Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Aspen Testosterone Undecanoate API Products Offered
7.4.5 Aspen Recent Development
7.5 Amber Lifesciences
7.5.1 Amber Lifesciences Company Information
7.5.2 Amber Lifesciences Business Overview
7.5.3 Amber Lifesciences Testosterone Undecanoate API Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Amber Lifesciences Testosterone Undecanoate API Products Offered
7.5.5 Amber Lifesciences Recent Development
7.6 Trifarma
7.6.1 Trifarma Company Information
7.6.2 Trifarma Business Overview
7.6.3 Trifarma Testosterone Undecanoate API Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Trifarma Testosterone Undecanoate API Products Offered
7.6.5 Trifarma Recent Development
7.7 ASG Biochem
7.7.1 ASG Biochem Company Information
7.7.2 ASG Biochem Business Overview
7.7.3 ASG Biochem Testosterone Undecanoate API Sales, Revenue and Gross Margin (2020-2025)
7.7.4 ASG Biochem Testosterone Undecanoate API Products Offered
7.7.5 ASG Biochem Recent Development
7.8 Huvepharma
7.8.1 Huvepharma Company Information
7.8.2 Huvepharma Business Overview
7.8.3 Huvepharma Testosterone Undecanoate API Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Huvepharma Testosterone Undecanoate API Products Offered
7.8.5 Huvepharma Recent Development
7.9 Xianju Pharmaceutical
7.9.1 Xianju Pharmaceutical Company Information
7.9.2 Xianju Pharmaceutical Business Overview
7.9.3 Xianju Pharmaceutical Testosterone Undecanoate API Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Xianju Pharmaceutical Testosterone Undecanoate API Products Offered
7.9.5 Xianju Pharmaceutical Recent Development
7.10 Zhejiang Shenzhou Pharmaceutical
7.10.1 Zhejiang Shenzhou Pharmaceutical Company Information
7.10.2 Zhejiang Shenzhou Pharmaceutical Business Overview
7.10.3 Zhejiang Shenzhou Pharmaceutical Testosterone Undecanoate API Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Zhejiang Shenzhou Pharmaceutical Testosterone Undecanoate API Products Offered
7.10.5 Zhejiang Shenzhou Pharmaceutical Recent Development
8 Testosterone Undecanoate API Manufacturing Cost Analysis
8.1 Testosterone Undecanoate API Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Testosterone Undecanoate API
8.4 Testosterone Undecanoate API Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Testosterone Undecanoate API Distributors List
9.3 Testosterone Undecanoate API Customers
10 Testosterone Undecanoate API Market Dynamics
10.1 Testosterone Undecanoate API Industry Trends
10.2 Testosterone Undecanoate API Market Drivers
10.3 Testosterone Undecanoate API Market Challenges
10.4 Testosterone Undecanoate API Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Testosterone Undecanoate API market is projected to grow from US$ 160 million in 2025 to US$ 221 million by 2032, at a CAGR of 4.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-12
Pages: 138
USD 4900.00
(Single User License)
The global Testosterone Undecanoate API market size was US$ 160 million in 2025 and is forecast to reach a readjusted size of US$ 221 million by 2032 with a CAGR of 4.8% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 78
USD 4250.00
(Single User License)
The global Testosterone Undecanoate API market was valued at US$ 160 million in 2025 and is anticipated to reach US$ 221 million by 2032, at a CAGR of 4.8% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 130
USD 2900.00
(Single User License)
The global market for Testosterone Undecanoate API was estimated to be worth US$ 160 million in 2025 and is projected to reach US$ 221 million, growing at a CAGR of 4.8% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 92
USD 3950.00
(Single User License)
The global market for Testosterone Undecanoate API was valued at US$ 153 million in the year 2024 and is projected to reach a revised size of US$ 212 million by 2031, growing at a CAGR of 4.8% during the forecast period.
Published Date: 2025-07-07
Pages: 92
USD 2900.00
(Single User License)
The global market for Testosterone Undecanoate API was estimated to be worth US$ 153 million in 2024 and is forecast to a readjusted size of US$ 212 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published Date: 2025-07-07
Pages: 103
USD 3950.00
(Single User License)
The global Testosterone Undecanoate API market is projected to grow from US$ 160 million in 2025 to US$ 212 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period.
Published Date: 2025-07-07
Pages: 138
USD 4900.00
(Single User License)
The global Testosterone Undecanoate API market is projected to grow from US$ 160 million in 2025 to US$ 221 million by 2032, at a CAGR of 4.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 138
The global Testosterone Undecanoate API market size was US$ 160 million in 2025 and is forecast to reach a readjusted size of US$ 221 million by 2032 with a CAGR of 4.8% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 78
The global Testosterone Undecanoate API market was valued at US$ 160 million in 2025 and is anticipated to reach US$ 221 million by 2032, at a CAGR of 4.8% from 2026 to 2032.
Published: 2026-03-12
Pages: 130
The global market for Testosterone Undecanoate API was estimated to be worth US$ 160 million in 2025 and is projected to reach US$ 221 million, growing at a CAGR of 4.8% from 2026 to 2032.
Published: 2026-03-09
Pages: 92
The global market for Testosterone Undecanoate API was valued at US$ 153 million in the year 2024 and is projected to reach a revised size of US$ 212 million by 2031, growing at a CAGR of 4.8% during the forecast period.
Published: 2025-07-07
Pages: 92
The global market for Testosterone Undecanoate API was estimated to be worth US$ 153 million in 2024 and is forecast to a readjusted size of US$ 212 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published: 2025-07-07
Pages: 103
The global Testosterone Undecanoate API market is projected to grow from US$ 160 million in 2025 to US$ 212 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period.
Published: 2025-07-07
Pages: 138
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now